시장보고서
상품코드
1293851

혈소판풍부혈장(PRP) 시장 : 성장, 미래 전망, 경쟁 분석(2023-2031년)

Platelet Rich Plasma (PRP) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈소판풍부혈장(PRP) 시장은 2031년까지 14.5% 성장할 것으로 예상됩니다. 혈소판풍부혈장(PRP)은 소량의 혈장에 다수의 혈소판을 함유한 제품으로, 조직 봉합 및 지혈 특성을 가진 피브린 조직 접착제 역할을 하며, 혈소판이 적은 조직이나 피브린 접착제와 다른 점은 PRP가 상처 치유 과정과 뼈 형성을 강화하는 고유한 능력을 제공한다는 점입니다. PRP는 표피, 상피 및 내피의 재생을 촉진하고, 콜라겐 합성을 촉진하고, 혈관 신생을 촉진하고, 진피 흉터를 줄이고, 연조직 치유를 강화하고, 글루코코르티코이드에 의한 치유 억제를 역전시키는 등 안전하고 생체적합성이 높은 빠른 지혈제 역할을 합니다. 고농도의 백혈구는 추가적인 항균 효과를 제공합니다.

PRP는 이비인후과, 일반외과, 미용 및 성형외과, 화상 및 창상 치료, 심혈관 수술, 구강 및 악안면 수술 등 다양한 임상 치료 용도로 사용되고 있으며, 만성 비치유성 창상 치료에 효과적임이 입증되어 혈관신생억제제로도 사용되고 있습니다. 외과수술에서 PRP는 기증자 및 수혜자 부위 모두에서 수술 후 및 수술 전 출혈의 위험을 줄이고, 연조직의 치유를 향상시키며, 접착력과 응집력으로 수혜자 부위에서 이식 조직의 안정성을 촉진합니다.

목차

제1장 서문

  • 리포트 내용
    • 보고서의 목적
    • 대상 독자
    • 주요 제공 상품
  • 시장 세분화
  • 조사 방법

제2장 주요 요약

제3장 혈소판풍부혈장(PRP) 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택하는 전략
  • 주요 산업 전략
  • Tier 분석 : 2022 vs 2031

제4장 혈소판풍부혈장(PRP) 시장 : 거시적 분석과 시장 역학

  • 서론
  • 세계의 혈소판풍부혈장(PRP) 시장 금액 2021-2031
  • 시장 역학
    • 시장 촉진요인
    • 시장 억제요인
    • 주요 과제
    • 주요 기회
  • 촉진요인과 억제요인의 영향 분석
  • 시소 분석

제5장 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 순수 PRP
    • 백혈구를 많이 포함한 PRP
    • 기타

제6장 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 정형외과
    • 스포츠 의학
    • 미용성형
    • 피부과
      • 궤양 치유
      • 기타
    • 안과 수술
    • 신경외과
    • 일반 외과
    • 기타

제7장 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031

  • 시장 개요
  • 성장·매출 분석 : 2022 vs 2031
  • 시장 세분화
    • 병원
    • 클리닉
    • 기타

제8장 북미의 혈소판풍부혈장(PRP) 시장 2021-2031

  • 시장 개요
  • 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 지역별 2021-2031
    • 북미
      • 미국
      • 캐나다
      • 기타 북미 지역

제9장 영국·유럽연합의 혈소판풍부혈장(PRP) 시장 2021-2031

  • 시장 개요
  • 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 지역별 2021-2031
    • 영국·유럽연합
      • 영국
      • 독일
      • 스페인
      • 이탈리아
      • 프랑스
      • 기타 유럽 지역

제10장 아시아태평양의 혈소판풍부혈장(PRP) 시장 2021-2031

  • 시장 개요
  • 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 지역별 2021-2031
    • 아시아태평양
      • 중국
      • 일본
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양

제11장 라틴아메리카의 혈소판풍부혈장(PRP) 시장 2021-2031

  • 시장 개요
  • 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 지역별 2021-2031
    • 라틴아메리카
      • 브라질
      • 멕시코
      • 기타 라틴아메리카 지역

제12장 중동 및 아프리카의 혈소판풍부혈장(PRP) 시장 2021-2031

  • 시장 개요
  • 혈소판풍부혈장(PRP) 시장 : 유형별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 최종 용도별 2021-2031
  • 혈소판풍부혈장(PRP) 시장 : 지역별 2021-2031
    • 중동 및 아프리카
      • GCC
      • 아프리카
      • 기타 중동 및 아프리카

제13장 기업 개요

  • Johnson & Johnson Services Inc.
  • Arthrex Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences Inc.
KSA 23.07.04

Platelet Rich Plasma (PRP) Market is Expected to Grow at 14.5% by 2031. Platelet rich plasma (PRP) is a product that contains large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because PRP provides a unique ability to augment wound healing process and osteogenesis. PRP functions as a safe, biocompatible prompt hemostatic agent and fast-tracks epidermal, epithelial and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing and reverses inhibition of glucocorticoid would healing. High concentration of leukocyte in PRP offers additional antimicrobial effect.

PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery and aesthetics, burn and would healing, cardiovascular surgery, oral and maxillofacial surgical procedures and others. PRP has proven effectiveness in treating chronic non-healing wounds and has been adopted as antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability to grafted tissue at the recipient site owing to its adhesive and cohesive properties.

Key players identified for platelet rich plasma market include but are not limited to:

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Platelet Rich Plasma (PRP) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Platelet Rich Plasma (PRP) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Segmentation

Type

  • Pure Platelet Rich Plasma
  • Leukocyte Rich Platelet Rich Plasma
  • Others

Application

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
    • Ulcer Healing
      • Venous Ulcer
      • Traumatic Ulcer
      • Diabetic Ulcer
      • Pyoderma Gangrenosum Ulcer
      • Trophic Ulcer
      • Vasculitic Ulcer
      • Others
    • Others
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

End-use

  • Hospitals
  • Clinics
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Platelet Rich Plasma (PRP) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Platelet Rich Plasma (PRP) market?
  • Which is the largest regional market for Platelet Rich Plasma (PRP) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Platelet Rich Plasma (PRP) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Platelet Rich Plasma (PRP) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Platelet Rich Plasma (PRP) Market
  • 2.2. Global Platelet Rich Plasma (PRP) Market, By Type, 2022 (US$ Million)
  • 2.3. Global Platelet Rich Plasma (PRP) Market, By Application, 2022 (US$ Million)
  • 2.4. Global Platelet Rich Plasma (PRP) Market, By End-use, 2022 (US$ Million)
  • 2.5. Global Platelet Rich Plasma (PRP) Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Platelet Rich Plasma (PRP) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Platelet Rich Plasma (PRP) Market Vendors
  • 3.2. Strategies Adopted by Platelet Rich Plasma (PRP) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Platelet Rich Plasma (PRP) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Platelet Rich Plasma (PRP) Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Pure Platelet Rich Plasma
    • 5.3.2. Leukocyte Rich Platelet Rich Plasma
    • 5.3.3. Others

6. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Orthopedics
    • 6.3.2. Sports Medicine
    • 6.3.3. Cosmetic Surgery
    • 6.3.4. Dermatology
      • 6.3.4.1. Ulcer Healing
        • 6.3.4.1.1. Venous Ulcer
        • 6.3.4.1.2. Traumatic Ulcer
        • 6.3.4.1.3. Diabetic Ulcer
        • 6.3.4.1.4. Pyoderma Gangrenosum Ulcer
        • 6.3.4.1.5. Trophic Ulcer
        • 6.3.4.1.6. Vasculitic Ulcer
        • 6.3.4.1.7. Others
      • 6.3.4.2. Others
    • 6.3.5. Ophthalmic Surgery
    • 6.3.6. Neurosurgery
    • 6.3.7. General Surgery
    • 6.3.8. Others

7. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others

8. North America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 8.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 8.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 8.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 9.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 9.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 9.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 10.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 10.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 10.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

11. Latin America Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 11.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 11.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 11.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Platelet Rich Plasma (PRP) Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
  • 12.3. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
  • 12.4. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
  • 12.5.Platelet Rich Plasma (PRP) Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Platelet Rich Plasma (PRP) Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Johnson & Johnson Services, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Arthrex, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. EmCyte Corporation
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Dr PRP USA LLC
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Juventix Regenerative Medical, LLC.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Terumo Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Zimmer Biomet
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Stryker
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Apex Biologix
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Celling Biosciences, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제